Clinical Trial Update: Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating antifungal prophylaxis in patients with graft-versus-host disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Samsung Medical Center | Conditions: Graft vs Host Disease | Phase 4 | Status: TERMINATED